7-105110773-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_182931.3(KMT2E):c.3973C>T(p.Pro1325Ser) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000427 in 1,612,630 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_182931.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
KMT2E | NM_182931.3 | c.3973C>T | p.Pro1325Ser | missense_variant, splice_region_variant | 26/27 | ENST00000311117.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
KMT2E | ENST00000311117.8 | c.3973C>T | p.Pro1325Ser | missense_variant, splice_region_variant | 26/27 | 1 | NM_182931.3 | P4 |
Frequencies
GnomAD3 genomes AF: 0.000467 AC: 71AN: 152006Hom.: 1 Cov.: 31
GnomAD3 exomes AF: 0.000358 AC: 90AN: 251306Hom.: 0 AF XY: 0.000331 AC XY: 45AN XY: 135824
GnomAD4 exome AF: 0.000423 AC: 618AN: 1460506Hom.: 0 Cov.: 30 AF XY: 0.000389 AC XY: 283AN XY: 726642
GnomAD4 genome AF: 0.000467 AC: 71AN: 152124Hom.: 1 Cov.: 31 AF XY: 0.000471 AC XY: 35AN XY: 74370
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 26, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 10, 2024 | - - |
KMT2E-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 01, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at